Charité Comprehensive Cancer Center

Berlin

1 studies enrolling now · 1 studies all time

What they study most

NSCLC

Studies at this site

• A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies — Recruiting now